树脂化物纳米颗粒对细胞线粒体活性的影响:对癌症治疗的影响
Agnieszka Nowak-Terpiłowska1, Mahreen Akhtar2, Gulzar Hussain2
1Department of Biochemistry and Biotechnology, Poznan University of Life Science, Dojazd 11, 60-632, Poznan, Poland.
Scientific reports
|July 2, 2025
概括
较小的树脂化物 (Bi2Se3) 纳米颗粒通过破坏线粒体,显示出增强的癌症治疗潜力. 牙纤维细胞比舌头癌细胞更敏感,突出了细胞特异性反应.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 纳米粒子 (NP) 在癌症治疗中具有潜力,但它们的机制和细胞类型特异性细胞毒性需要进一步研究.
- 石化物 (Bi2Se3) 纳米粒子正在探索治疗应用.
- 了解NP细胞相互作用对于开发安全有效的癌症治疗至关重要.
研究的目的:
- 研究Bi2Se3纳米颗粒在舌头癌细胞 (SCC-25) 和牙纤维细胞中的细胞毒性和线粒体作用.
- 确定结晶体大小对Bi2Se3NP细胞毒性机制的影响.
- 为了探索细胞特异性对Bi2Se3 NP暴露的反应.
主要方法:
- Bi2Se3纳米粒子的溶热合成.
- 使用X射线衍射 (XRD),扫描电子显微镜 (SEM) 和传输电子显微镜 (TEM) 的表征.
- 在SCC-25和牙纤维细胞系中24小时暴露后评估细胞活力和线粒体影响.
主要成果:
- Bi2Se3纳米粒子表现出六角结构,其晶体体大小约为15nm.
- 在24小时暴露后,在两种细胞类型中都观察到细胞活力的显著降低.
- 与舌头癌细胞相比,牙纤维细胞对Bi2Se3NP具有更高的敏感性.
- 减少的晶体大小与增强的细胞毒性相关,表明纳米粒子-细胞相互作用和线粒体破坏的增加.
结论:
- Bi2Se3纳米颗粒大小和晶体体大小对细胞毒性有重大影响.
- 对Bi2Se3NP的细胞特异性反应表明对线粒体毒性的脆弱性不同.
- 通过考虑NP大小和细胞选择性相互作用,研究结果支持开发基于Bi2Se3的向和安全的癌症疗法.
相关概念视频
01:46Electron Transport Chain: Complex I and II
15.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
01:10Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K